Social memory is impaired in neonatally ibotenic acid lesioned rats

Behavioural Brain Research

Volumn 109, Issue 1, 2000, Pages 137-140

  Becker, Axel ^a   Grecksch, Gisela ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Ibotenic acid; Postnatal hippocampal lesion; Rat; Schizophrenia; Social memory

Indexed keywords

HALOPERIDOL; IBOTENIC ACID;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; LEARNING; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SHORT SURVEY; SOCIAL BEHAVIOR; SOCIAL DISABILITY;

EID: 0033969824     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00163-1     Document Type: Article

References (26)

1. Anglade F., Chapouthier G., Dodd R.H., Baudoin C. Olfactory memory in rats, cholinergic agents and benzodiazepine receptor ligands. J. Physiol. (Paris). 93:1999;225-232.
2. Becker A., Grecksch G., Bernstein H.G., Höllt V., Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology. 144:1999;333-338.
3. Bedard M.A., Scherer H., Delorimier J., Stip E., Lalonde P. Differential effects of D2- and D4-blocking neuroleptics on the procedural learning of schizophrenic patients. Can. J. Psychiatr. 41:1996;S21-S24.
4. Bernstein H.G., Grecksch G., Becker A., Höllt V., Bogerts B. Cellular changes in rat brain areas associated with neonatal hippocampal damage. Neuroreport. 10:1999;2307-2311.
5. Cadenhead K.S., Perry W., Shafer K., Braff D.L. Cognitive functions in schizotypal personality disorder. Schizophr. Res. 37:1999;123-132.
6. Chambers R.A., Moore J., McEvoy J.P., Levin E.D. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology. 15:1996;587-594.
7. Glenthoj B.Y., Mackeprang T., Bille A., Hemmingsen R. Transmitter dysfunction in schizophrenia: Implications for cognitive functioning and treatment. Int. J. Psychiatr. Clin. Pract. 2(Suppl. 2):1998;S21-S32.
8. Goldberg T.E., Weinberger D.R. Effects of neuroleptic medication on the cognition of patients with schizophrenia: a review of recent studies. J. Clin. Psychiatr. 57(9):1996;62-65.
9. Grecksch G., Bernstein H.G., Becker A., Höllt V., Bogerts B. Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology. 20:1999;525-532.
10. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatr. 153:1999;321-330.
11. Guan X., Dluzen D.E. Age related changes of social memory/recognition in male Fischer 344 rats. Behav. Brain. Res. 61:1994;87-90.
12. Hemsley D.R. Schizophrenia. A cognitive model and its implications for the psychological intervention. Behav. Mod. 20:1996;139-169.
13. Kern R.S., Green M.F., Marshall B.D.J. et al. Risperidone versus haloperidol on secondary memory: can newer medications aid learning? Schizophr. Bull. 25:1999;223-232.
14. Lipska B.K., Jaskiw G.E., Chrapusta S., Karoum F., Weinberger D.R. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 585:1999;1-6.
15. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 9:1999;67-75.
16. Lipska B.K., Weinberger D.R. Cortical regulation of the mesolimbic dopamine system: implications for schizophrenia. Kalivas P., Barnes C. Mesolimbic Motor Circuits and its Role in Neuropsychiatric Disorders. 1993;329-349 CRC Press, Boca Raton.
17. Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 25:1999;233-255.
18. Mondadori C., Moebius H.J., Zingg M. CGP 36,742, an orally active GABAB receptor antagonist, facilitates memory in a social recognition test in rats. Behav. Brain. Res. 77:1996;227-229.
19. Park S., Puschel J., Sauter B.H., Rentsch M., Hell D. Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study. Biol. Psychiatr. 46:1999;392-400.
20. Popik P., Wolterink G., De Brabander H., van Ree J.M. Neuropeptides related to [Arg8]vasopressin facilitates social recognition in rats. Physiol. Behav. 49:1991;1031-1035.
21. Popik PI. Neurohypophyseal peptides and social recognition in rats. PhD Thesis, Rijksuniversiteit te Utrecht, Netherlands, 1991.
22. Schroeder H., Grecksch G., Becker A., Bogerts B., Hoellt V. Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology. 145:1999;61-66.
23. Skarsfeldt T. Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology (Berlin). 124:1996;126-132.
24. Snitz B.E., Curtis C.E., Zald D.H., Katsanis J., Iacono W.G. Neuropsychological and oculomotor correlates of spatial working memory performance in schizophrenia patients and controls. Schizophr. Res. 38:1999;37-50.
25. Taylor G., Farr S., Griffin M., Humphrey W., Weiss J. Adult ontogeny of rat working memory of social interactions. J. Gerontol. A. Biol. Sci. Med. Sci. 54:1999;145-151.
26. Thor D.H., Holloway W.R. Social memory of the male laboratory rat. J. Comp. Physiol. Psychol. 96:1982;1000-1006.